Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath

University Hospital Southampton NHS Foundation Trust.

Professor Gareth Thomas is Chair of Experimental Pathology at the University of Southampton. His laboratory focuses on the role of the tumour microenvironment in promoting tumour progression, investigating the interactions between different cell types. The work has a strong translational component, identifying potential prognostic/predictive biomarkers, therapeutic targets and molecular classifiers in cancer tissues, including the characterisation of cancer-associated fibroblasts and intratumoral immune cells, and development of immunotherapy clinical trials in squamous carcinoma of the head and neck.

dont miss

Targeted therapies: aiming at the tumour micro-environment

While immune checkpoint inhibitors such as -PD1, have shown efficacy across cancer types, most patients (~80%) fail to respond. Currently, it is unclear how to select patients most likely to benefit, or how to combine the expanding number of immunotherapies in development.

Our aim is to develop immune stratification for cancer patients; using NGS, bioinformatic analyses and in vivo modelling, we have characterised the molecular heterogeneity of tumour phenotypes; characterising prognostic/predictive lymphocyte signatures and identifying targetable immune evasion mechanisms. The seminar will discuss the potential for immune-based classification of cancers.

EVEN MORE SEMINARS

  • Camilo Colaco: Speaking at the Oncology Convention

    Camilo Colaco
    ImmunoBiology

    The immunobiology of immunotherapy

  • Professor David Maintz: Speaking at the Oncology Convention

    Professor David Maintz
    University Hospital Cologne, Department of Radiology

    Spectral CT: Dual layer technology helps to increase diagnostic confidence

  • Mylaine Riobe MD, FABOIM, FACOG: Speaking at the Oncology Convention

    Mylaine Riobe MD, FABOIM, FACOG
    Riobe Institute of Integrative Medicine

    Cancer is not random! Evolving mechanisms for cancer causation and prevention

  • Professor Alex Mirnezami: Speaking at the Oncology Convention

    Professor Alex Mirnezami
    University of Southampton

    Biomarkers of Epithelial to Mesenchymal Transition and their clinical relevance in colorectal cancer

  • Professor Patricia Price: Speaking at the Oncology Convention

    Professor Patricia Price
    Action Radiotherapy

    Action Radiotherapy -a charity for radiotherapy patients and professionals.